242 related articles for article (PubMed ID: 29278308)
1. Effect of lysyl oxidase (LOX) on corpus cavernous fibrosis caused by ischaemic priapism.
Gao L; Wu C; Fu F; You X; Ma X; Qin F; Li T; Wang R; Yuan J
J Cell Mol Med; 2018 Mar; 22(3):2018-2022. PubMed ID: 29278308
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of Cavernosal Fibrosis and Erectile Function by Lysyl Oxidase Inhibition in a Rat Model of Cavernous Nerve Injury.
Wan ZH; Li GH; Guo YL; Li WZ; Chen L; Zhang YJ
J Sex Med; 2018 Mar; 15(3):304-313. PubMed ID: 29502979
[TBL] [Abstract][Full Text] [Related]
3. Crosslinking Enzyme Lysyl Oxidase Modulates Scleral Remodeling in Form-Deprivation Myopia.
Yuan Y; Li M; Chen Q; Me R; Yu Y; Gu Q; Shi G; Ke B
Curr Eye Res; 2018 Feb; 43(2):200-207. PubMed ID: 29135319
[TBL] [Abstract][Full Text] [Related]
4. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
[TBL] [Abstract][Full Text] [Related]
5. Anti-lysyl oxidase combined with a vacuum device induces penile lengthening by remodeling the tunica albuginea.
Li T; Fu FD; Wu CJ; Qin F; Wang R; Yuan JH
Asian J Androl; 2020; 22(5):485-492. PubMed ID: 31736474
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of penile growth in pubertal rats and a non-invasive method to lengthen the penis.
Li T; Fu F; Wu C; Qin F; Yuan J
Andrology; 2020 Nov; 8(6):1884-1894. PubMed ID: 32578359
[TBL] [Abstract][Full Text] [Related]
7. Intracellular lysyl oxidase: effect of a specific inhibitor on nuclear mass in proliferating cells.
Saad FA; Torres M; Wang H; Graham L
Biochem Biophys Res Commun; 2010 Jun; 396(4):944-9. PubMed ID: 20460108
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice.
Liu SB; Ikenaga N; Peng ZW; Sverdlov DY; Greenstein A; Smith V; Schuppan D; Popov Y
FASEB J; 2016 Apr; 30(4):1599-609. PubMed ID: 26700732
[TBL] [Abstract][Full Text] [Related]
9. The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats.
Martínez-Martínez E; Rodríguez C; Galán M; Miana M; Jurado-López R; Bartolomé MV; Luaces M; Islas F; Martínez-González J; López-Andrés N; Cachofeiro V
J Mol Cell Cardiol; 2016 Mar; 92():96-104. PubMed ID: 26780438
[TBL] [Abstract][Full Text] [Related]
10. Substrate Strain Mitigates Effects of β-Aminopropionitrile-Induced Reduction in Enzymatic Crosslinking.
Canelón SP; Wallace JM
Calcif Tissue Int; 2019 Dec; 105(6):660-669. PubMed ID: 31482192
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of resveratrol and beta-aminopropionitrile attenuates liver fibrosis development via targeting lysyl oxidase in CCl
Mohseni R; Arab Sadeghabadi Z; Goodarzi MT; Karimi J
Immunopharmacol Immunotoxicol; 2019 Dec; 41(6):644-651. PubMed ID: 31724452
[No Abstract] [Full Text] [Related]
12. β-Aminopropionitrile-Induced Reduction in Enzymatic Crosslinking Causes In Vitro Changes in Collagen Morphology and Molecular Composition.
Canelón SP; Wallace JM
PLoS One; 2016; 11(11):e0166392. PubMed ID: 27829073
[TBL] [Abstract][Full Text] [Related]
13. Targeting lysyl oxidase reduces peritoneal fibrosis.
Harlow CR; Wu X; van Deemter M; Gardiner F; Poland C; Green R; Sarvi S; Brown P; Kadler KE; Lu Y; Mason JI; Critchley HOD; Hillier SG
PLoS One; 2017; 12(8):e0183013. PubMed ID: 28800626
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells.
Lucero HA; Ravid K; Grimsby JL; Rich CB; DiCamillo SJ; Mäki JM; Myllyharju J; Kagan HM
J Biol Chem; 2008 Aug; 283(35):24103-17. PubMed ID: 18586678
[TBL] [Abstract][Full Text] [Related]
15. Acute lysyl oxidase inhibition alters microvascular function in normotensive but not hypertensive men and women.
Craighead DH; Wang H; Santhanam L; Alexander LM
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H424-H433. PubMed ID: 29167120
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of lysyl oxidase inhibition against volume overload-induced extracellular matrix remodeling.
El Hajj EC; El Hajj MC; Ninh VK; Gardner JD
Exp Biol Med (Maywood); 2016 Mar; 241(5):539-49. PubMed ID: 26582054
[TBL] [Abstract][Full Text] [Related]
18. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model.
Hu Y; Niu X; Wang G; Huang J; Liu M; Peng B
Andrology; 2016 Nov; 4(6):1209-1216. PubMed ID: 27565759
[TBL] [Abstract][Full Text] [Related]
19. A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase (LOX) limits VSMC proliferation and neointimal thickening through its extracellular enzymatic activity.
Varona S; Orriols M; Galán M; Guadall A; Cañes L; Aguiló S; Sirvent M; Martínez-González J; Rodríguez C
Sci Rep; 2018 Sep; 8(1):13258. PubMed ID: 30185869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
